MALT lymphoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 13: Line 13:
=== Associations ===
=== Associations ===
Gastric MALT lymphoma is frequently associated (72-98%) with chronic [[inflammation]] as a result of the presence of ''[[Helicobacter pylori]]''. <ref>{{cite journal | author = Parsonnet J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E, Orentreich N, Vogelman J, Friedman G | title = Helicobacter pylori infection and gastric lymphoma. | journal = N Engl J Med | volume = 330 | issue = 18 | pages = 1267-71 | year = 1994 | id = PMID 8145781}}</ref>
Gastric MALT lymphoma is frequently associated (72-98%) with chronic [[inflammation]] as a result of the presence of ''[[Helicobacter pylori]]''. <ref>{{cite journal | author = Parsonnet J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E, Orentreich N, Vogelman J, Friedman G | title = Helicobacter pylori infection and gastric lymphoma. | journal = N Engl J Med | volume = 330 | issue = 18 | pages = 1267-71 | year = 1994 | id = PMID 8145781}}</ref>
The initial diagnosis is made by [[biopsy]] of suspicious lesions on [[esophagogastroduodenoscopy]] (EGD, upper endoscopy). Simultaeneously tests for H pylori are also done to detect the presence of this microbe.


In other sites, chronic immune stimulation is also suspected in the pathogenesis (e.g. association between chronic [[autoimmune diseases]] such as [[Sjögren's syndrome]] and [[Hashimoto's thyroiditis]], and MALT lymphoma of the [[salivary gland]] and the [[thyroid]]).
In other sites, chronic immune stimulation is also suspected in the pathogenesis (e.g. association between chronic [[autoimmune diseases]] such as [[Sjögren's syndrome]] and [[Hashimoto's thyroiditis]], and MALT lymphoma of the [[salivary gland]] and the [[thyroid]]).

Revision as of 18:15, 24 August 2015

MALT lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating MALT Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

CT

MRI

Endoscopic Ultrasound

Biopsy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

MALT lymphoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of MALT lymphoma pathophysiology

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMALT lymphoma pathophysiology

CDC on MALT lymphoma pathophysiology

MALT lymphoma pathophysiology in the news

on MALT lymphoma pathophysiology

Directions to Hospitals Treating MALT lymphoma

Risk calculators and risk factors for MALT lymphoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

Genetics

A t(11;18)(q21;q21) chromosomal translocation, giving rise to a AP12-MLT fusion gene, is predictive of poor response to eradication therapy. [1]

Two other genetic alterations, t(1;14)(p22;q32) and t(14;18)(q32;q21), which deregulate BCL10 and MALT1-genes respectively, and seem to turn-on the same pathway as API2-MLT (i.e., that of NF-kB).

Associations

Gastric MALT lymphoma is frequently associated (72-98%) with chronic inflammation as a result of the presence of Helicobacter pylori. [2]

In other sites, chronic immune stimulation is also suspected in the pathogenesis (e.g. association between chronic autoimmune diseases such as Sjögren's syndrome and Hashimoto's thyroiditis, and MALT lymphoma of the salivary gland and the thyroid).

References

  1. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, Ye H, Molina T, Bouhnik Y, Hamoudi R, Diss T, Dogan A, Megraud F, Rambaud J, Du M, Isaacson P (2001). "Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy". Lancet. 357 (9249): 39–40. PMID 11197361.
  2. Parsonnet J, Hansen S, Rodriguez L, Gelb A, Warnke R, Jellum E, Orentreich N, Vogelman J, Friedman G (1994). "Helicobacter pylori infection and gastric lymphoma". N Engl J Med. 330 (18): 1267–71. PMID 8145781.


Template:WikiDoc Sources